Leila
Senior Member (Voting Rights)
Our fine fellow of a Prime Minister thinks that those on social security should have it first, or lose their benefits.![]()
Why?
Isn't it risk group and frontline health care workers first?
Our fine fellow of a Prime Minister thinks that those on social security should have it first, or lose their benefits.![]()
when/where did he say that?Our fine fellow of a Prime Minister thinks that those on social security should have it first, or lose their benefits.![]()
I think the reference might be to the Australian Prime Minister who seems to have backtracked:when/where did he say that?
If this article is true then having a covid vaccine is unlikely to prevent people getting the disease, it will allegedly, at best, just reduce the severity of symptoms. So, Covid-19 has brought in an entirely new definition of what a vaccine is intended to achieve.
That relies on others to wear masks and continued social distancing. I will gladly take any vaccine offered me that has been through testing and approval. I'd prefer to take the risk with that than be permanently isolated.@Jonathan Edwards
So wearing a mask is much better at preventing us from contracting the virus in the first place. Not as practical as getting a vaccine, but something I would prefer.
@Jonathan Edwards
So wearing a mask is much better at preventing us from contracting the virus in the first place. Not as practical as getting a vaccine, but something I would prefer.
The 6-minute walking test is rather high in this cohort. Although it's a low-intensity test so it has a very low ceiling. Looking at the SF-36, there is a wide range of functioning, from 45 to 90.Findings At 2-3 months from disease-onset, 64% of patients experienced persistent breathlessness and 55% complained of significant fatigue. On MRI, tissue signal abnormalities were seen in the lungs (60%), heart (26%), liver (10%) and kidneys (29%) of patients. COVID-19 patients also exhibited tissue changes in the thalamus, posterior thalamic radiations and sagittal stratum on brain MRI and demonstrated impaired cognitive performance, specifically in the executive and visuospatial domain relative to controls. Exercise tolerance (maximal oxygen consumption and ventilatory efficiency on CPET) and six-minute walk distance (405±118m vs 517±106m in controls, p<0.0001) were significantly reduced in patients. The extent of extra-pulmonary MRI abnormalities and exercise tolerance correlated with serum markers of ongoing inflammation and severity of acute illness. Patients were more likely to report symptoms of moderate to severe anxiety (35% versus 10%, p=0.012) and depression (39% versus 17%, p=0.036) and significant impairment in all domains of quality of life compared to controls. Interpretation A significant proportion of COVID-19 patients discharged from hospital experience ongoing symptoms of breathlessness, fatigue, anxiety, depression and exercise limitation at 2-3 months from disease-onset. Persistent lung and extra-pulmonary organ MRI findings are common. In COVID-19 survivors, chronic inflammation may underlie multiorgan abnormalities and contribute to impaired quality of life.
Vaccines have no ability to stop you getting infected. That happens when you breath in or swallow a virus. The point of the vaccine is to stop the virus then producing symptoms and signs - i.e. being ill - by preventing the virus from replicating. Which is the same as 'preventing people getting disease'.
I use as my yardstick the vaccinations I got as a child or young adult. I don't hear of outbreaks of (for example) diphtheria and whooping cough in the UK, and I was vaccinated against those.
BBC said:UK plan to be first to run human challenge Covid trials
By Michelle Roberts
Health editor, BBC News online
The UK is pushing ahead to be the first nation to carry out "human challenge" studies where up to 90 healthy people will be deliberately exposed to Covid.
The trials, which could begin in January, aim to speed up the race to get a Covid-19 vaccine.
The government is putting £33.6m towards the groundbreaking work.
Safety will be a number one priority, experts insist. The plans will need ethical approval and sign-off from regulators before they can go ahead.
Human challenge studies provide a faster way to test vaccines because you don't have to wait for people to be exposed to an illness naturally.
Researchers would first use controlled doses of the pandemic virus to discover what is the smallest amount that can cause Covid infection in volunteers aged 18 to 30.
These human guinea pigs, who will be infected with the virus through the nose and monitored around the clock, have the lowest risk of harm due to their young age and good health.
Next, scientists could test if a Covid vaccine prevents infection...
Israeli researchers claim to have identified coronavirus biomarkers — gases related to the virus — in the breath of infected patients.
They say these could be used to rapidly detect the virus through a breath test, with people having to blow into a tube to establish whether or not they have the disease.